Nature Medicine · 2023 · 164 citations · 33 references
MedicineImmunologyOncologyCancer ImmunologyHematologic OncologyImmunotherapyCancer ImmunotherapyChemotherapy In Hematologic MalignanciesChimeric Antigen Receptor T-cell TherapyCytotoxic T Lymphocyte ResponsesHematologic Malignancy TherapyRelapsed DiseaseCar T Cell TrialsLymphoma RelapseLymphoma Treatment ResponseRefractory Lymphoma CareRefractory Non-hodgkin LymphomaRelapsed Diffuse Large B-cell LymphomaRelapsed Lymphoid NeoplasmsT-cell Therapy
33
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett et al. · New England Journal of Medicine · 2017 · 5.9K citations · Full text
Medicine, Hematology, Oncology +16
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
Shannon L. Maude, Theodore W. Laetsch, Jochen Buechner et al. · New England Journal of Medicine · 2018 · 5.6K citations · Full text
Medicine, Hematology, Oncology +17
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter, Bruce L. Levine, Michael Kalos et al. · New England Journal of Medicine · 2011 · 3.5K citations · Full text
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
Jae H. Park, Isabelle Rivière, Mithat Gönen et al. · New England Journal of Medicine · 2018 · 2.7K citations · Full text
Life Sciences, Hematology, Oncology +17